Work

Author Correction: Targeting Hsp90 with FS-108 circumvents gefitinib resistance in EGFR mutant non-small cell lung cancer cells

Year: 2020

Type: erratum

Source: Acta Pharmacologica Sinica

DOI: 10.1038/s41401-019-0341-6

Authors: Yue-qin Wang, Ai-jun Shen, Jing-ya Sun, Xin Wang, Hong-chun Liu, Min-min Zhang, Dan-qi Chen, Bing Xiong, Jing-kang Shen, Mei-yu Geng, Min Zheng, Jian Ding

Institutions: China Pharmaceutical University, Chinese Academy of Sciences, Shanghai Institute of Materia Medica, State Key Laboratory of Drug Research, Shanghai Jiao Tong University, Tongren Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3007827807

Cites:

Cited by: 2

Related to: 10